of patient-reported nonadherence equivalent to major defaulting would be needed to accord estimates of 69 of patients made by their physicians (Table 2) days

The rate of reported major defaulting in the past (32.99 missing recent single doses (33.89) is similar; and cases of previous and current nonadherence (45.09) involved the same persons Both rates represent about one-third of all treated   patients with BPD some degree of treatment-nonadherence may be quite prevalent among contemporary American BPD patients. The apparently disparity between physicians impressions and   patient   self-reports is noteworthy; but may reflect differences in definitions of nonadherence , such that physicians self-defined nonadherence was likely to reflect clinically important whereas patients were asked about even single missed many large

These   self-reports of incomplete   adherence with prescribed treatments for BPD in one-third of patients limited by the very sensitive standard applied in an effort to detect the worst case for incomplete treatment-adherence In addition to the self-reported, recent incomplete   treatment-adherence noted. of   patients also   reported   having discontinued all recommended medications for BPD at some without   informing their initiated   discontinuation of treatment, among 130 patients providing such information; ranked: (a) not needing it any longer (22.39) > (b) no longer wanting to take it (18.59) > (c) side effects (13.19]) > (d) feeling better at the time (10.89). point

## Patient assessments of illness and its treatment

When asked a general question about major frustrations illness as as its treatment (Table Most commonly 423 patients providing such data were: mood swings (66.4 > depression (56.39) > need for   daily   selfmedication (51.19) > stigma of considered mentally ill (43.59) ships side-effects (40.29). nonadherence, patients   with self-reported ranked: weight-gain (58.59) > excessive sedation (54.29) > physical awk wardness or tremor (33.19). well %o) being

Table 3 Major frustrations reported by BPD patients

| Characteristic                                        | %o         |
|-------------------------------------------------------|------------|
| Illness-related factors                               |            |
| Mood swings                                           | 281 (66.4) |
| Depressions                                           | 238 (56.3) |
| Others ' perceptionslstigma                           | 184 (43.5) |
| Problems with trustlrelationshipslsocial interactions | 171 (40.4) |
| Holding down job                                      |            |
| Hospitalization                                       |            |
| Highs of mood                                         | 115 (27.2) |
| Lack of information                                   | 26 (6.15)  |
| Treatment-related factors                             |            |
| Taking medication every day                           | 216 (51.1) |
| Medication side-effects                               | 170 (40.2) |
| Cost of treatment                                     | 3 (0.71)   |
| Miscellaneous factors                                 |            |
| Other                                                 |            |

person (1708/423).

## Physician assessments of treatment

When   psychiatrists were asked to report   improvements in treatments for BPD patients needed to increase acceptance and adherence to treatment, the was the need for better mood-stabilization in 48.09 of their 429 patients. In addition; identified freedom from weight-: as important treatment-acceptance among 29.19 of their   patients , and improvement of treatment30.89 also estiexperienced adverse effects of   psychotropic medi cations at some time in the past, that adverse effects were of current concern to 14.09 of patients (60/429), and were considered by their physicians to be severe in 15.09 (9/60) of that subgroup. Psychiatrists reported experienced  weight-gain in association  with current treatment; with substantial prevalence of hyperlipide mia (19.19) and diabetes (8.629) and identified these as problems of particular clinical concern. they gain They

## Univariate analyses of factors associated with treatment-nonadherence

PSF and PRF questionnaires, which yielded a total of 59 variables tentatively related to treatment adherence, based on   initial univariate comparisons (p<0.10), and 43 significantly (p < 0.05) associated